Orange Nutraceutical Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 2.00 M
as on 24-10-2024
- Company Age 9 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 Cr
as on 24-10-2024
- Revenue -19.49%
(FY 2023)
- Profit -138.89%
(FY 2023)
- Ebitda 327.41%
(FY 2023)
- Net Worth -31.79%
(FY 2023)
- Total Assets 31.07%
(FY 2023)
About Orange Nutraceutical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.20 Cr.
Karamvir Phagna and Shashi Phagna serve as directors at the Company.
- CIN/LLPIN
U15311GJ2015PTC085298
- Company No.
085298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Orange Nutraceutical Private Limited offer?
Orange Nutraceutical Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Honey & Sweeteners, Ayurvedic,Herbal Drops & Concentrates, Popular Category, Diabetes Care.
Who are the key members and board of directors at Orange Nutraceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karamvir Phagna  | Managing Director | 01-Feb-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shashi Phagna | Whole-Time Director | 31-Aug-2020 | Current |
Financial Performance of Orange Nutraceutical.
Orange Nutraceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.49% decrease. The company also saw a substantial fall in profitability, with a 138.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orange Nutraceutical?
In 2023, Orange Nutraceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 13 Oct 2017 | ₹1.20 Cr | Open |
How Many Employees Work at Orange Nutraceutical?
Unlock and access historical data on people associated with Orange Nutraceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orange Nutraceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orange Nutraceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
